Genotype/phenotype analyses of low frequency tumor cells using computerized image microscopy

Cytometry

Volumn 23, Issue 4, 1996, Pages 344-349

  Litle, Virginia R ^a   Lockett, Steven J ^b   Pallavicini, Maria G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Aneusomy; Fluorescence in situ hybridization; Image cytometry; Immunocytochemistry; Micrometastases; Rare tumor cells

Indexed keywords

CYTOKERATIN;

ARTICLE; BONE MARROW METASTASIS; COLON CARCINOMA; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL;

GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; MICROSCOPY, FLUORESCENCE; PHENOTYPE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

UNIDENTIFIED AGENTS;

EID: 0029932249     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960401)23:4<344::AID-CYTO11>3.0.CO;2-T     Document Type: Article

References (22)

1. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ, Osborne MP: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12:333-340, 1988.
2. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 73:563-569, 1994.
3. Gross H-J, Verwer B, Houck D, Recktenwald D: Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14:519-526, 1993.
4. Johnson GD, Nogueria JGM: A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 43: 349-350, 1981.
5. Knuutila S, Teerenhovi L: Immunophenotyping of aneuploid cells. Cancer Genet Cytogenet 41:1-17, 1989.
6. Mansi JL, Berger U, McDonnell T, Pople A, Rayter Z, Gazet JC, Coombes RC: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7:445-449, 1989.
7. Mansi JL, Berger LT, Wilson P, Shearer R, Coombes RC: Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 139:545-548, 1988.
8. Mogensen J, Kolvraa S, Hindkjaer J, Petersen S, Koch J, Nygaard M, Jensen T, Gregersen N, Junker S, Bolund L: Nonradioactive, sequence-specific detection of RNA in situ by primed in situ labelling (PRINS). Exp Cell Res 196:92-98, 1990.
9. Moll R, Lowe A, Laufer J, Franke WW: Cytokeratin 20 in human carcinomas: A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447, 1992.
10. Mullink H, Walboomers JMM, Tadema TM, Jansen DJ, Meijer CJLM: Combined immuno- and non-radioactive hybridocytochemistry on cells and tissue sections: Influence of fixation, enzyme pre-treatment, and choice of chromogen on detection of antigen and DNA sequences. J Histochem Cytochem 37:603-609, 1989.
11. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, Thetter O, Riethmuller G: Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer Cancer Res 53:1027-1031, 1993
12. Pantel K, Schlimock G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmuller G: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424, 1993.
13. Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938, 1986.
14. Piper J, Poggensee M, Hill W, Jensen R, Ji L, Poole I, Stark M, Sudar D: Automatic fluorescence metaphase finder speeds translocation scoring in FISH painted chromosomes. Cytometry 16:7-16, 1994.
15. Rodriguez E, Sreckantaiah C, Chaganti RSK: Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406, 1994.
16. Schlimok G, Funke I, Holzmann B, Gottlinger G, Schmidt G, Hauser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H: Micrometastatic cancer cells in bone marrow: In vitro detection with anticytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84:8672-8676, 1987.
17. Sedmak DD, Meineke TA, Knechtges DS: Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med 113:786-789, 1989.
18. Strenl S, Ambros PF: Fluorescence in situ hybridization combined with immunohistochemistry for highly sensitive detection of chromosome 1 aberrations in neuroblastoma. Cytogenet Cell Genet 63: 24-28, 1993.
19. van Balen R, Koelma D, ten Kate TK, Mosterd B, Smeulders AWM: Scillmage: A multi-layered environment for use and development of image processing software In: Experimental Environments for Computer Vision and Image Processing, Christensen HI, Crowley JL (eds). World Scientific Publishing Co. Pte Ltd, London, 1994, pp 107-126.
20. van den Berg H, Vossen JM, van den Bergh RL, Bayer J, van Tol MJD: Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence. Lab Invest 64:623, 1991.
21. Weber-Matthiesen K, Deerberg J, Muller-Hermelink A, Schlegelberger B, Grote W: Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method. Cytogenet Cell Genet 63:123-125, 1993.
22. Weber-Matthiesen K, Winkemann M. Muller-Hermelink A, Schlegelberger B, Grote W: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: A contribution to the characterization of tumor cells. J Histochem Cytochem 40:171-175, 1992.